These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia]. Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G Therapie; 1978; 33(5):615-22. PubMed ID: 217121 [No Abstract] [Full Text] [Related]
3. Cholestyramine for elevated serum cholesterol. Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570 [No Abstract] [Full Text] [Related]
4. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial. Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640 [No Abstract] [Full Text] [Related]
5. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation]. Bye A; Brox D Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134 [No Abstract] [Full Text] [Related]
6. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia. Mann JI; Harding PA; Turner RC; Wilkinson RH Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982 [TBL] [Abstract][Full Text] [Related]
7. Should hyperlipoproteinemia be treated in patients with coronary artery disease? Rider AK JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412 [No Abstract] [Full Text] [Related]
8. [Action of cholestyramine on blood lipids]. Giannini SD; Forti NA; Timoner M; Campanari JC Arq Bras Cardiol; 1977 Aug; 30(4):293-6. PubMed ID: 603433 [No Abstract] [Full Text] [Related]
9. High fiber diet in hyperlipemia. Comparison with cholestyramine treatment in type IIA hyperlipoproteinemia. Palumbo PJ; Briones ER; Nelson RA JAMA; 1978 Jul; 240(3):223-7. PubMed ID: 660847 [TBL] [Abstract][Full Text] [Related]
10. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
11. Drug treatment of hyperlipidemia. Spector AA J Iowa Med Soc; 1972 Oct; 62(10):524-5 passim. PubMed ID: 5074337 [No Abstract] [Full Text] [Related]
12. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia]. Carlson LA; Olsson AG; Orö L; Rössner S Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566 [No Abstract] [Full Text] [Related]
13. Lipoprotein lipid alterations with cholestyramine administration. Jones RJ; Dobrilovic L J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080 [No Abstract] [Full Text] [Related]
14. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases]. Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729 [TBL] [Abstract][Full Text] [Related]
15. Hypolipidemic effect of polyvinylpyrrolidone in man. Sanbar SS; Smet G Circulation; 1968 Oct; 38(4):771-6. PubMed ID: 5677962 [No Abstract] [Full Text] [Related]
16. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [TBL] [Abstract][Full Text] [Related]
17. Hypercholesterolemia and hypertriglyceridemia in children. Fallat RW; Tsang RC; Glueck CJ Prev Med; 1974 Sep; 3(3):390-405. PubMed ID: 4413730 [No Abstract] [Full Text] [Related]
18. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia]. Huth K; Blumenthal J; Schmahl FW Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868 [No Abstract] [Full Text] [Related]
19. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II. Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122 [TBL] [Abstract][Full Text] [Related]
20. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia. Glueck CJ; Ford S; Scheel D; Steiner P JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098 [No Abstract] [Full Text] [Related] [Next] [New Search]